glp-1 forums April Functional Forum: Agonists Ozempic, Mounjaro & Co.: Erstes

The Phase 2 clinical trial of CagriSema which combined cagrilintide and semaglutide led to 15.6% weight reduction in T2DM patients while achieving superior glycemic control and better outcomes than each drug alone [53,54]

Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isnt serious enough for treatment, said David A Ricks, chair and CEO of Eli Lilly, in a statement

Nevertheless, this building evidence has triggered calls to explore GLP-1RAs as novel treatments to reduce stroke risk and improve neurological outcomes in at-risk populations (196, 198)

Does it actually work

Injecting through clothing or into areas with poor hygiene increases infection risk